Veru, Inc. (VERU)
2.80
+0.18
(+6.67%)
USD |
NASDAQ |
Aug 31, 16:00
2.79
-0.01
(-0.36%)
After-Hours: 20:00
Veru Total Long Term Debt (Quarterly) : 1.908M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.908M |
| March 31, 2026 | 2.063M |
| December 31, 2025 | 2.213M |
| September 30, 2025 | 2.358M |
| June 30, 2025 | 2.501M |
| March 31, 2025 | 2.641M |
| December 31, 2024 | 2.775M |
| September 30, 2024 | 12.78M |
| June 30, 2024 | 12.64M |
| March 31, 2024 | 12.99M |
| December 31, 2023 | 13.17M |
| September 30, 2023 | 13.37M |
| June 30, 2023 | 14.14M |
| March 31, 2023 | 15.60M |
| December 31, 2022 | 16.20M |
| September 30, 2022 | 14.92M |
| June 30, 2022 | 18.87M |
| March 31, 2022 | 19.40M |
| December 31, 2021 | 13.74M |
| September 30, 2021 | 10.02M |
| June 30, 2021 | 11.48M |
| March 31, 2021 | 9.504M |
| December 31, 2020 | 8.824M |
| September 30, 2020 | 12.48M |
| June 30, 2020 | 13.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.31M |
| December 31, 2019 | 14.24M |
| September 30, 2019 | 12.12M |
| June 30, 2019 | 10.97M |
| March 31, 2019 | 8.554M |
| December 31, 2018 | 7.940M |
| September 30, 2018 | 11.15M |
| June 30, 2018 | 10.70M |
| March 31, 2018 | 9.736M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Johnson & Johnson | 37.34B |
| Eli Lilly & Co. | 49.62B |
| Lexicon Pharmaceuticals, Inc. | 57.60M |